Pregnancy warning means heightened caution where evidence is limited and fetal risk could outweigh routine benefit claims.
Why it matters
Risks differ by trimester and by lactation context, so a broad category label is insufficient.
Trimester and lactation distinctions
- First trimester: avoid non-essential, non-protocol compounds where alternatives exist
- Second/third trimester: focus on proven-needed compounds only, with tighter dose review
- Breastfeeding: extra caution with transfer, excipients, and uncertain concentration peaks
Stop conditions
Stop and escalate to clinician quickly for:
- planned dosing changes without medical oversight
- nausea, dizziness, bleeding, cramping, or unusual fluid shifts
- any medication/supplement overlap that cannot be reconciled
Evidence status
For many common products, safety data is incomplete in pregnant and lactating populations.
Treat unknowns as pause-and-review cases.
Practical action step
When pregnancy or lactation is possible, share a medication and supplement reconciliation packet with your clinician before each stack activation.
Uncertainty and limits
- Evidence is limited on long-term outcomes for many compounds in these populations.
- Evidence is limited on safe upper thresholds for combined supplements during active pregnancy stages.
Cross-site references
How this appears in Unfair
Pregnancy warning tags increase safety-first recommendations and suppress non-essential experimentation pathways.
Clinical safety note
When uncertainty is high, pause escalation and prefer direct medical review over app-optimized changes.